Estrogen receptor polymorphisms and the risk of endometrial cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 8, 2009, Pages 1053-1061

  Ashton, K A ^a   Proietto, A ^a,b   Otton, G ^a,b   Symonds, I ^a   McEvoy, M ^a   Attia, J ^a   Gilbert, M ^c   Hamann, U ^c   Scott, R J ^a,d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Cancer genetics; Endometrial cancer; Estrogen receptors; Polymorphisms

Indexed keywords

ESTROGEN RECEPTOR;

ALLELE; ARTICLE; AUSTRALIA; CALCULATION; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIUM CANCER; ESR1 GENE; ESR2 GENE; FEMALE; GENDER; GENE; GENETIC MODEL; GENOTYPE; HAPLOTYPE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RISK FACTORS;

EID: 67651108734     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2009.02185.x     Document Type: Article

References (19)

1. Kufe D, Bast R, Hait W, Hong W, Pollack R, Weichselbaum R, et al. Cancer Medicine, 7th edn. Columbia : BC Decker Inc, 2006. 1522 36.
2. Key T, Pike M. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988 57 : 205 12.
3. Yager J, Davidson N. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006 354 : 270 82.
4. Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, Bocchinfuso WP, et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003 86 : 477 86.
5. Katzenellenbogen B, Choi I, Delage-Mourroux R, Ediger T, Martini P, Montano M, et al. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 2000 74 : 279 85.
6. Katzenellenbogen B, Montano M, Ediger T, Sun J, Ekena K, Lazennec G, et al. Estrogen receptors: selective ligands, partners, and distinctive pharmacology. Recent Prog Horm Res 2000 55 : 163 93 discussion 94-5.
7. Ogawa S, Eng V, Taylor J, Lubahn D, Korach K, Pfaff D. Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology 1998 139 : 5070 81.
8. Beleza-Meireles A, Omrani D, Kockum I, Frisen L, Lagerstedt K, Nordenskjold A. Polymorphisms of estrogen receptor beta gene are associated with hypospadias. J Endocrinol Invest 2006 29 : 5 10. (Pubitemid 43361419)
9. Iwamoto I, Fujino T, Douchi T, Nagata Y. Association of estrogen receptor alpha and beta3-adrenergic receptor polymorphisms with endometrial cancer. Obstet Gynecol 2003 102 : 506 11.
10. Roodi N, Bailey L, Kao W, Verrier C, Yee C, Dupont W, et al. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst 1995 87 : 446 51.
11. Yaich L, Dupont WD, Cavener DR, Parl FF. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res 1992 52 : 77 83.
12. Maguire P, Margolin S, Skoglund J, Sun X, Gustafsson J, Borresen-Dale A, et al. Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer. Breast Cancer Res Treat 2005 94 : 145 52.
13. Sowers M, Jannausch M, McConnell D, Kardia S, Randolph JJ. Endogenous estradiol and its association with estrogen receptor gene polymorphisms. Am J Med 2006 9 (Suppl 1 S16 22.
14. Setiawan VW, Hankinson SE, Colditz GA, Hunter D, De Vivo I. Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States). Cancer Causes Control 2004 15 : 627 33.
15. Weiderpass E, Persson I, Melhus H, Wedren S, Kindmark A, Baron J. Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 2000 21 : 623 7.
16. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. Polymorphisms of estrogen receptor alpha gene in endometrial cancer. Biochem Biophys Res Commun 2002 297 : 558 64.
17. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 16 : 1215.
18. Forsti A, Zhao C, Israelsson E, Dahlman-Wright K, Gustafsson J, Hemminki K. Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association. Breast Cancer Res Treat 2003 79 : 409 13.
19. McCaskie P, Carter K, Palmer L. A comprehensive modelling framework and a multiple-imputation approach to haplotypic analysis of population-based data. 2004 SimHap: [online] [ http://www.genepi.org.au/simhap.html ]. Accessed 6 April 2009.